Login to Your Account

Funding Crisis Threatens Mental Illness Drug R&D

By Nuala Moran

Wednesday, June 22, 2011
LONDON – A funding crisis is threatening the development of new drugs for treating mental illness following the "abrupt" withdrawal by pharma companies from research in the field, coupled with a reduction in public sector investment, according to the European College of Neuropsychopharmacology (ECNP). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription